Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Organoid Research Center, Shanghai University, Shanghai, 200444, China.
J Mater Chem B. 2023 Sep 20;11(36):8565-8585. doi: 10.1039/d3tb00925d.
Bone tumors, including primary bone tumors and bone metastases, have been plagued by poor prognosis for decades. Although most tumor tissue is removed, clinicians are still confronted with the dilemma of eliminating residual cancer cells and regenerating defective bone tissue after surgery. Therefore, functional biomaterial scaffolds are considered to be the ideal candidates to bridge defective tissues and restrain cancer recurrence. Through functionalized structural modifications or coupled therapeutic agents, they provide sufficient mechanical strength and osteoinductive effects while eliminating cancer cells. Numerous novel approaches such as photodynamic, photothermal, drug-conjugated, and immune adjuvant-assisted therapies have exhibited remarkable efficacy against tumors while exhibiting low immunogenicity. This review summarizes the progress of research on biomaterial scaffolds based on different functionalization strategies in bone tumors. We also discuss the feasibility and advantages of the combined application of multiple functionalization strategies. Finally, potential obstacles to the clinical translation of anti-tumor bone bioscaffolds are highlighted. This review will provide valuable references for future advanced biomaterial scaffold design and clinical bone tumor therapy.
骨肿瘤,包括原发性骨肿瘤和骨转移瘤,几十年来一直预后不良。尽管大部分肿瘤组织已被切除,但临床医生仍面临着消除手术后残留癌细胞和再生受损骨组织的困境。因此,功能性生物材料支架被认为是桥接缺陷组织和抑制癌症复发的理想候选物。通过功能化的结构修饰或偶联治疗剂,它们在消除癌细胞的同时提供足够的机械强度和成骨诱导作用。许多新方法,如光动力、光热、药物偶联和免疫佐剂辅助治疗,在表现出低免疫原性的同时,对肿瘤显示出显著的疗效。本文综述了基于不同功能化策略的生物材料支架在骨肿瘤研究中的进展。我们还讨论了多种功能化策略联合应用的可行性和优势。最后,强调了抗肿瘤骨生物支架临床转化的潜在障碍。本文的综述将为未来先进的生物材料支架设计和临床骨肿瘤治疗提供有价值的参考。